Literature DB >> 29695182

The application of in vitro human intestinal models on the screening and development of pre- and probiotics.

V T Pham1, M H Mohajeri1,2.   

Abstract

The importance of the gut microbiota community on host's health and disease has long been recognised and is well documented. The development of pro- and prebiotic interventions offers an opportunity for the modulation of the gut microbiota towards long lasting health. In vitro fermentation models were developed as a powerful tool to study the impact of pro- and prebiotics on the gut microbiota under tightly controlled conditions, which allow dynamic sampling over time in reactors mimicking different colon regions. These models have been further evolved to suit specific experimental purposes, e.g. including immobilised faecal microbiota, peristaltic movement, mucin microcosm and the ability to perform treatments in parallel. In this review we discuss the advantages, disadvantages and technical considerations of the most frequently used models. We further focus on recent advances in the application of these models in prebiotics and probiotics research and outline their predictability for clinical research.

Entities:  

Keywords:  fermentation; gut microbiota; healthy gut; screening

Mesh:

Substances:

Year:  2018        PMID: 29695182     DOI: 10.3920/BM2017.0164

Source DB:  PubMed          Journal:  Benef Microbes        ISSN: 1876-2883            Impact factor:   4.205


  19 in total

1.  An In Vitro Enrichment Strategy for Formulating Synergistic Synbiotics.

Authors:  Car Reen Kok; David Fabian Gomez Quintero; Clement Niyirora; Devin Rose; Amanda Li; Robert Hutkins
Journal:  Appl Environ Microbiol       Date:  2019-08-01       Impact factor: 4.792

2.  Similarities and differences of oligo/poly-saccharides' impact on human fecal microbiota identified by in vitro fermentation.

Authors:  Shanshan Wang; Xiaojuan Zhang; Heng Li; Yilin Ren; Yan Geng; Zhenming Lu; Jinsong Shi; Zhenghong Xu
Journal:  Appl Microbiol Biotechnol       Date:  2021-09-06       Impact factor: 5.560

3.  Effects of Zymosan on Short-Chain Fatty Acid and Gas Production in in vitro Fermentation Models of the Human Intestinal Microbiota.

Authors:  Xionge Pi; Zaichun Yu; Xiaoxia Yang; Zhi Du; Wei Liu
Journal:  Front Nutr       Date:  2022-07-04

4.  MiniBioReactor Array (MBRA) in vitro gut model: a reliable system to study microbiota-dependent response to antibiotic treatment.

Authors:  C A Hobson; L Vigue; S Naimi; B Chassaing; M Magnan; S Bonacorsi; B Gachet; I El Meouche; A Birgy; O Tenaillon
Journal:  JAC Antimicrob Resist       Date:  2022-07-05

5.  An in vitro batch fermentation protocol for studying the contribution of food to gut microbiota composition and functionality.

Authors:  Sergio Pérez-Burillo; Silvia Molino; Beatriz Navajas-Porras; Álvaro Jesús Valverde-Moya; Daniel Hinojosa-Nogueira; Alicia López-Maldonado; Silvia Pastoriza; José Ángel Rufián-Henares
Journal:  Nat Protoc       Date:  2021-06-04       Impact factor: 13.491

6.  Effects of Rich in Β-Glucans Edible Mushrooms on Aging Gut Microbiota Characteristics: An In Vitro Study.

Authors:  Evdokia K Mitsou; Georgia Saxami; Emmanuela Stamoulou; Evangelia Kerezoudi; Eirini Terzi; Georgios Koutrotsios; Georgios Bekiaris; Georgios I Zervakis; Konstantinos C Mountzouris; Vasiliki Pletsa; Adamantini Kyriacou
Journal:  Molecules       Date:  2020-06-18       Impact factor: 4.411

7.  The effects of fermentation products of prebiotic fibres on gut barrier and immune functions in vitro.

Authors:  Van T Pham; Nicole Seifert; Nathalie Richard; Daniel Raederstorff; Robert E Steinert; Kevin Prudence; M Hasan Mohajeri
Journal:  PeerJ       Date:  2018-08-10       Impact factor: 2.984

Review 8.  Synthetic gut microbiome: Advances and challenges.

Authors:  Humphrey A Mabwi; Eunjung Kim; Dae-Geun Song; Hyo Shin Yoon; Cheol-Ho Pan; Erick V G Komba; GwangPyo Ko; Kwang Hyun Cha
Journal:  Comput Struct Biotechnol J       Date:  2020-12-24       Impact factor: 7.271

Review 9.  The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics.

Authors:  Kelly S Swanson; Glenn R Gibson; Robert Hutkins; Raylene A Reimer; Gregor Reid; Kristin Verbeke; Karen P Scott; Hannah D Holscher; Meghan B Azad; Nathalie M Delzenne; Mary Ellen Sanders
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-08-21       Impact factor: 46.802

10.  W27 IgA suppresses growth of Escherichia in an in vitro model of the human intestinal microbiota.

Authors:  Kengo Sasaki; Tomoyuki Mori; Namiko Hoshi; Daisuke Sasaki; Jun Inoue; Reiko Shinkura; Akihiko Kondo
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.